How much is the companion animal pain management market worth?

In 2027, the market for companion animal pain management is worth approximately USD 2.23 billion.

How is the companion animal pain management industry size expected to evolve during the forecast period?

Companion Animal Pain Management Market size was over USD 2.11 billion in 2026 and is likely to grow at a 6.57% CAGR between 2027 and 2036, surpassing USD 3.99 billion by 2036.

How is growing pet healthcare awareness influencing demand for companion animal pain management?

Greater attention to animal welfare and preventive care is encouraging pet owners to seek timely veterinary treatment for chronic conditions, injuries, surgical recovery, and age-related disorders, supporting more consistent pain diagnosis and therapy adoption.

How are advanced therapies changing veterinary pain management practices?

Targeted treatments and multimodal approaches are giving veterinarians greater flexibility to address varying pain sources and severity, while increasing emphasis on individualized care is encouraging broader adoption of advanced therapeutic strategies.

Which animal type dominates the companion animal pain management market?

Dogs accounted for 59.64% of the market in 2026 and were also the fastest-growing animal segment, driven by demand for pain management for injuries, musculoskeletal disorders, postoperative discomfort, and age-related conditions.

Which product type is expected to grow fastest in the companion animal pain management market?

Laser therapy is the fastest-growing product type, supported by increasing interest in non-invasive, drug-sparing treatments and its use in multimodal approaches for inflammation, soft-tissue injuries, musculoskeletal discomfort, and postoperative recovery.

Why does North America lead the companion animal pain management market?

North America leads through established veterinary infrastructure, rising pet ownership, and greater awareness of animal pain treatment, supporting demand for specialized care and targeted pain management solutions.

What is driving companion animal pain management market growth in Asia Pacific?

Asia Pacific is growing rapidly as pet ownership expands, veterinary access improves, and rising disposable incomes support greater spending on pet healthcare and pain management.

Who are the major participants shaping the companion animal pain management landscape?

Leading companies in the companion animal pain management market include Zoetis (USA), Elanco (USA), Boehringer Ingelheim (Germany), Merck Animal Health (USA), Dechra Pharmaceuticals (UK), Ceva Santé Animale (France), Virbac (France), Vetoquinol (France), Norbrook Laboratories (UK), Phibro Animal Health (USA).